Harvard Bioscience, Inc. HBIO

Company Overview

Harvard Bioscience, Inc. (NASDAQ: HBIO) is a life sciences company that develops, manufactures, and sells specialized products used in preclinical research, drug discovery, physiological testing, and laboratory automation. The company primarily serves academic institutions, pharmaceutical and biotechnology companies, contract research organizations (CROs), and government research laboratories. HBIO operates within the broader scientific instruments and laboratory equipment industry, with a focus on tools that support neuroscience, cell biology, respiratory studies, cardiovascular research, and molecular analysis.

The company’s core revenue drivers include precision instrumentation, data acquisition systems, laboratory software, and consumable products used in biological research workflows. HBIO has historically differentiated itself through a portfolio of niche scientific brands and integrated research platforms designed for highly specialized laboratory applications. Founded in 1901 as Harvard Apparatus, the business evolved through acquisitions and portfolio expansion into a diversified life sciences tools provider. Over time, the company consolidated multiple scientific equipment brands under the Harvard Bioscience corporate structure while focusing increasingly on higher-margin and technology-driven research instrumentation.